Kangmei Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 933.85 million compared to CNY 1,087.76 million a year ago. Revenue was CNY 933.85 million compared to CNY 1,087.76 million a year ago. Net loss was CNY 111.42 million compared to CNY 595.23 million a year ago. Basic loss per share from continuing operations was CNY 0.008 compared to CNY 0.121 a year ago. Diluted loss per share from continuing operations was CNY 0.008 compared to CNY 0.121 a year ago.